First Turn Management »

Praxis Precision Medicines I shares owned by First Turn Management

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by First Turn Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.7M 72k 37.87
2024-12-31 $3.5M 46k 76.96

More positions owned by First Turn Management

Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
United Therapeutics Corporation (UTHR)
Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Bridgebio Pharma (BBIO)
Revolution Medicines (RVMD)
Ascendis Pharma A/s Sponsored Adr (ASND)
Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Oric Pharmaceuticals (ORIC)
Arcellx Common Stock (ACLX)
Neurocrine Biosciences (NBIX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for First Turn Management

Top funds holding Praxis Precision Medicines I

Henderson Group
Adage Capital Partners GP
BlackRock
Perceptive Advisors
Point72 Asset Management
Vanguard Group
Morgan Stanley
Cormorant Asset Management
State Street Corporation
Soleus Capital Management
Deerfield Management Company
Baker Bros. Advisors
Goldman Sachs Group
Driehaus Capital Management
Geode Capital Management

View all funds holding Praxis Precision Medicines I